Asia-Pacific Hereditary Angioedema Drug Market Report 2019

Table of Contents

Asia-Pacific Hereditary Angioedema Drug Market Report 2017
1 Hereditary Angioedema Drug Overview
1.1 Product Overview and Scope of Hereditary Angioedema Drug
1.2 Classification of Hereditary Angioedema Drug by Product Category
1.2.1 Asia-Pacific Hereditary Angioedema Drug Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Hereditary Angioedema Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 C1 Esterase Inhibitor
1.2.4 Kallikrein Inhibitor
1.2.5 Selective Bradykinin B2 Receptor Antagonist
1.3 Asia-Pacific Hereditary Angioedema Drug Market by Application/End Users
1.3.1 Asia-Pacific Hereditary Angioedema Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Asia-Pacific Hereditary Angioedema Drug Market by Region
1.4.1 Asia-Pacific Hereditary Angioedema Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Hereditary Angioedema Drug (2012-2022)
1.5.1 Asia-Pacific Hereditary Angioedema Drug Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Hereditary Angioedema Drug Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Hereditary Angioedema Drug Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Hereditary Angioedema Drug Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Hereditary Angioedema Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Hereditary Angioedema Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Hereditary Angioedema Drug (Volume and Value) by Type
2.2.1 Asia-Pacific Hereditary Angioedema Drug Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Hereditary Angioedema Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Hereditary Angioedema Drug (Volume) by Application
2.4 Asia-Pacific Hereditary Angioedema Drug (Volume and Value) by Region
2.4.1 Asia-Pacific Hereditary Angioedema Drug Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Hereditary Angioedema Drug Revenue and Market Share by Region (2012-2017)

3 China Hereditary Angioedema Drug (Volume, Value and Sales Price)
3.1 China Hereditary Angioedema Drug Sales and Value (2012-2017)
3.1.1 China Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2017)
3.1.2 China Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
3.1.3 China Hereditary Angioedema Drug Sales Price Trend (2012-2017)
3.2 China Hereditary Angioedema Drug Sales Volume and Market Share by Type
3.3 China Hereditary Angioedema Drug Sales Volume and Market Share by Application

4 Japan Hereditary Angioedema Drug (Volume, Value and Sales Price)
4.1 Japan Hereditary Angioedema Drug Sales and Value (2012-2017)
4.1.1 Japan Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
4.1.3 Japan Hereditary Angioedema Drug Sales Price Trend (2012-2017)
4.2 Japan Hereditary Angioedema Drug Sales Volume and Market Share by Type
4.3 Japan Hereditary Angioedema Drug Sales Volume and Market Share by Application

5 South Korea Hereditary Angioedema Drug (Volume, Value and Sales Price)
5.1 South Korea Hereditary Angioedema Drug Sales and Value (2012-2017)
5.1.1 South Korea Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Hereditary Angioedema Drug Sales Price Trend (2012-2017)
5.2 South Korea Hereditary Angioedema Drug Sales Volume and Market Share by Type
5.3 South Korea Hereditary Angioedema Drug Sales Volume and Market Share by Application

6 Taiwan Hereditary Angioedema Drug (Volume, Value and Sales Price)
6.1 Taiwan Hereditary Angioedema Drug Sales and Value (2012-2017)
6.1.1 Taiwan Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Hereditary Angioedema Drug Sales Price Trend (2012-2017)
6.2 Taiwan Hereditary Angioedema Drug Sales Volume and Market Share by Type
6.3 Taiwan Hereditary Angioedema Drug Sales Volume and Market Share by Application

7 India Hereditary Angioedema Drug (Volume, Value and Sales Price)
7.1 India Hereditary Angioedema Drug Sales and Value (2012-2017)
7.1.1 India Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2017)
7.1.2 India Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
7.1.3 India Hereditary Angioedema Drug Sales Price Trend (2012-2017)
7.2 India Hereditary Angioedema Drug Sales Volume and Market Share by Type
7.3 India Hereditary Angioedema Drug Sales Volume and Market Share by Application

8 Southeast Asia Hereditary Angioedema Drug (Volume, Value and Sales Price)
8.1 Southeast Asia Hereditary Angioedema Drug Sales and Value (2012-2017)
8.1.1 Southeast Asia Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Hereditary Angioedema Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia Hereditary Angioedema Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Hereditary Angioedema Drug Sales Volume and Market Share by Application

9 Australia Hereditary Angioedema Drug (Volume, Value and Sales Price)
9.1 Australia Hereditary Angioedema Drug Sales and Value (2012-2017)
9.1.1 Australia Hereditary Angioedema Drug Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Hereditary Angioedema Drug Revenue and Growth Rate (2012-2017)
9.1.3 Australia Hereditary Angioedema Drug Sales Price Trend (2012-2017)
9.2 Australia Hereditary Angioedema Drug Sales Volume and Market Share by Type
9.3 Australia Hereditary Angioedema Drug Sales Volume and Market Share by Application

10 Asia-Pacific Hereditary Angioedema Drug Players/Suppliers Profiles and Sales Data
10.1 Pharming Group NV
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Hereditary Angioedema Drug Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Shire plc
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Hereditary Angioedema Drug Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Shire plc Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 CSL Limited
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Hereditary Angioedema Drug Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 iBio Inc.
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Hereditary Angioedema Drug Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 iBio Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 BioCryst Pharmaceuticals, Inc.
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Hereditary Angioedema Drug Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Ionis Pharmaceuticals, Inc.
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Hereditary Angioedema Drug Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
...

11 Hereditary Angioedema Drug Manufacturing Cost Analysis
11.1 Hereditary Angioedema Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Hereditary Angioedema Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Hereditary Angioedema Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Hereditary Angioedema Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Hereditary Angioedema Drug Market Forecast (2017-2022)
15.1 Asia-Pacific Hereditary Angioedema Drug Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Hereditary Angioedema Drug Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Hereditary Angioedema Drug Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Hereditary Angioedema Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Hereditary Angioedema Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Hereditary Angioedema Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Hereditary Angioedema Drug Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Hereditary Angioedema Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Hereditary Angioedema Drug Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Hereditary Angioedema Drug Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Hereditary Angioedema Drug Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Hereditary Angioedema Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Hereditary Angioedema Drug Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Hereditary Angioedema Drug
Figure Asia-Pacific Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure C1 Esterase Inhibitor Product Picture
Figure Kallikrein Inhibitor Product Picture
Figure Selective Bradykinin B2 Receptor Antagonist Product Picture
Figure Asia-Pacific Hereditary Angioedema Drug Sales (MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Hereditary Angioedema Drug by Application in 2016
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Asia-Pacific Hereditary Angioedema Drug Market Size (Million USD) by Region (2012-2022)
Figure China Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Market Major Players Product Sales Volume (MT)(2012-2017)
Table Asia-Pacific Hereditary Angioedema Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Hereditary Angioedema Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Hereditary Angioedema Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Hereditary Angioedema Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Hereditary Angioedema Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Hereditary Angioedema Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Hereditary Angioedema Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Hereditary Angioedema Drug Revenue Share by Players
Figure 2017 Asia-Pacific Hereditary Angioedema Drug Revenue Share by Players
Table Asia-Pacific Hereditary Angioedema Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Hereditary Angioedema Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Hereditary Angioedema Drug by Type (2012-2017)
Figure Asia-Pacific Hereditary Angioedema Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Hereditary Angioedema Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Hereditary Angioedema Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hereditary Angioedema Drug by Type (2012-2017)
Figure Asia-Pacific Hereditary Angioedema Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Hereditary Angioedema Drug Sales Volume (MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Hereditary Angioedema Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Hereditary Angioedema Drug by Region (2012-2017)
Figure Asia-Pacific Hereditary Angioedema Drug Sales Market Share by Region in 2016
Table Asia-Pacific Hereditary Angioedema Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Hereditary Angioedema Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Hereditary Angioedema Drug by Region (2012-2017)
Figure Asia-Pacific Hereditary Angioedema Drug Revenue Market Share by Region in 2016
Table Asia-Pacific Hereditary Angioedema Drug Sales Volume (MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Hereditary Angioedema Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Hereditary Angioedema Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Hereditary Angioedema Drug Sales Market Share by Application (2012-2017)
Figure China Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure China Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table China Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table China Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure China Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table China Hereditary Angioedema Drug Sales Volume (MT) by Applications (2012-2017)
Table China Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure China Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure Japan Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Japan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table Japan Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table Japan Hereditary Angioedema Drug Sales Volume (MT) by Applications (2012-2017)
Table Japan Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure South Korea Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure South Korea Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table South Korea Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table South Korea Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table South Korea Hereditary Angioedema Drug Sales Volume (MT) by Applications (2012-2017)
Table South Korea Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure Taiwan Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Taiwan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Taiwan Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table Taiwan Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table Taiwan Hereditary Angioedema Drug Sales Volume (MT) by Applications (2012-2017)
Table Taiwan Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure India Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure India Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table India Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table India Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure India Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table India Hereditary Angioedema Drug Sales Volume (MT) by Application (2012-2017)
Table India Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure India Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Hereditary Angioedema Drug Sales Volume (MT) by Applications (2012-2017)
Table Southeast Asia Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Figure Australia Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Australia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Hereditary Angioedema Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Australia Hereditary Angioedema Drug Sales Volume (MT) by Type (2012-2017)
Table Australia Hereditary Angioedema Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia Hereditary Angioedema Drug Sales Volume Market Share by Type in 2016
Table Australia Hereditary Angioedema Drug Sales Volume (MT) by Applications (2012-2017)
Table Australia Hereditary Angioedema Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia Hereditary Angioedema Drug Sales Volume Market Share by Application in 2016
Table Pharming Group NV Hereditary Angioedema Drug Basic Information List
Table Pharming Group NV Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Shire plc Hereditary Angioedema Drug Basic Information List
Table Shire plc Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table CSL Limited Hereditary Angioedema Drug Basic Information List
Table CSL Limited Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table iBio Inc. Hereditary Angioedema Drug Basic Information List
Table iBio Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Basic Information List
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Basic Information List
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Kg) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hereditary Angioedema Drug
Figure Manufacturing Process Analysis of Hereditary Angioedema Drug
Figure Hereditary Angioedema Drug Industrial Chain Analysis
Table Raw Materials Sources of Hereditary Angioedema Drug Major Manufacturers in 2016
Table Major Buyers of Hereditary Angioedema Drug
Table Distributors/Traders List
Figure Asia-Pacific Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Price (USD/Kg) and Trend Forecast (2017-2022)
Table Asia-Pacific Hereditary Angioedema Drug Sales Volume (MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Hereditary Angioedema Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Revenue Market Share Forecast by Region in 2022
Figure China Hereditary Angioedema Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure China Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Hereditary Angioedema Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Hereditary Angioedema Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Hereditary Angioedema Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Hereditary Angioedema Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure India Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hereditary Angioedema Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Hereditary Angioedema Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Australia Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Hereditary Angioedema Drug Sales (MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Hereditary Angioedema Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Hereditary Angioedema Drug Price (USD/Kg) Forecast by Type (2017-2022)
Table Asia-Pacific Hereditary Angioedema Drug Sales (MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Hereditary Angioedema Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources